Quality of life in COVID-19 survivors

Quality of life in COVID-19 survivors after discharge from the hospital: a prospective observational multicenter study.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON22071

Enrollment

500

Registered

2020-05-06

Start date

2020-05-07

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None

Eligibility

Inclusion criteria

Inclusion criteria: - Male or female older than 18 years of age; - Tested positive for COVID-19; - Being discharged from the hospital after admission for COVID-19; - Provided written informed consent.

Exclusion criteria

Exclusion criteria: - Patients who are not able to understand the Dutch language or are otherwise not able to fill in questionnaires during the follow-up procedures; - Patients who are living in a nursing home because of a diagnosis of dementia.

Design outcomes

Primary

Measure	Time frame
Generic quality of life, measured with the 5-level EQ-5D questionnaire	—

Secondary

Measure	Time frame
- Quality of life, measured with Clinical COPD Questionnaire (at discharge, 2, 6 and 12 weeks after discharge); - Fatigue, measured with the Checklist Individual Strength – Fatigue domain (at discharge, 2, 6 and 12 weeks after discharge); - Symptoms of dry mouth, pain, muscle weakness etc., measured with the Utrecht Symptom Diary (at discharge, 2, 6 and 12 weeks after discharge); - Symptoms of anxiety and depression, measured with the Hospital Anxiety and Depression Scale (at discharge, 2, 6 and 12 weeks after discharge); - The level of care dependency, measured with the Care Dependency Scale (at discharge, 2, 6 and 12 weeks after discharge); - Self-reported functional status, measured with Post COVID-19 Functional status Scale - Impairments in work and activities, measured with the Work Productivity and Activity Impairment instrument (2, 6 and 12 weeks after discharge); - Post-traumatic stress, measured with the Trauma Screening Questionnaire (12 weeks after discharge); - Handgrip muscle strength, measured using a JAMAR hand dynamometer (at discharge); - Functional mobility, measured with the Short Physical Performance Battery (at discharge).	—

Measure

Time frame

- Quality of life, measured with Clinical COPD Questionnaire (at discharge, 2, 6 and 12 weeks after discharge); - Fatigue, measured with the Checklist Individual Strength – Fatigue domain (at discharge, 2, 6 and 12 weeks after discharge); - Symptoms of dry mouth, pain, muscle weakness etc., measured with the Utrecht Symptom Diary (at discharge, 2, 6 and 12 weeks after discharge); - Symptoms of anxiety and depression, measured with the Hospital Anxiety and Depression Scale (at discharge, 2, 6 and 12 weeks after discharge); - The level of care dependency, measured with the Care Dependency Scale (at discharge, 2, 6 and 12 weeks after discharge); - Self-reported functional status, measured with Post COVID-19 Functional status Scale - Impairments in work and activities, measured with the Work Productivity and Activity Impairment instrument (2, 6 and 12 weeks after discharge); - Post-traumatic stress, measured with the Trauma Screening Questionnaire (12 weeks after discharge); - Handgrip muscle strength, measured using a JAMAR hand dynamometer (at discharge); - Functional mobility, measured with the Short Physical Performance Battery (at discharge).

—

Contacts

Public ContactMartijn Spruit

CIRO Horn

martijnspruit@ciro-horn.nl+31 (0)475 587 600

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)